- Home
- GRX vs TARA Comparison
GRX vs TARA Comparison
Compare GRX & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRX | TARA |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.2M | 165.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GRX | TARA |
|---|---|---|
| Price | $9.58 | $5.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 39.7K | ★ 810.0K |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 5.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $38.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $2.77 |
| 52 Week High | $10.40 | $7.82 |
Technical Indicators
Market Signals| Indicator | GRX | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 51.84 |
| Support Level | $9.53 | $5.03 |
| Resistance Level | $9.70 | $5.87 |
| Average True Range (ATR) | 0.10 | 0.30 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 63.16 | 75.60 |
Price Performance
Historical ComparisonAbout GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).